Structures by: Yathirajan H. S.
Total: 746
4-[(<i>E</i>)-(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidinium picrate
C12H15F2N2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2365-o2366
a=6.0926(4)Å b=13.5364(8)Å c=24.0417(14)Å
α=90.00° β=92.671(6)° γ=90.00°
(<i>E</i>)-1-(1,3-Benzodioxol-5-yl)-3-(3-bromophenyl)prop-2-en-1-one
C16H11BrO3
Acta Crystallographica Section E (2008) 64, 12 o2387
a=14.237(3)Å b=8.1811(17)Å c=11.717(2)Å
α=90.00° β=100.658(3)° γ=90.00°
Gabapentinium picrate
C9H18NO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 4 o783
a=11.576(2)Å b=7.7312(16)Å c=19.973(4)Å
α=90.00° β=91.425(2)° γ=90.00°
Ethyl 6-(6-methoxy-2-naphthyl)-2-oxo-4-(2-thienyl)cyclohex-3-ene-1-carboxylate
C24H22O4S
Acta Crystallographica Section E (2009) 65, 7 o1533
a=18.2501(4)Å b=11.7176(2)Å c=9.6846(2)Å
α=90.00° β=93.0480(10)° γ=90.00°
4-(2,2-Diphenyl-2-propoxyacetoxy)-1-methylpiperidin-1-ium picrate
C23H30NO3,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 8 o1738-o1739
a=8.9379(4)Å b=9.2885(4)Å c=18.0750(7)Å
α=97.652(3)° β=97.630(3)° γ=104.301(4)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>] pyrimidinium-4-one picrate
C11H12ClN2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 9 o2201-o2202
a=7.2718(5)Å b=12.8159(9)Å c=19.940(3)Å
α=90.00° β=97.642(9)° γ=90.00°
Haloperidol picrate
C21H24ClFNO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2403-o2404
a=14.9089(5)Å b=12.5934(3)Å c=14.5074(5)Å
α=90.00° β=90.00° γ=90.00°
1-(2-methyl-5-nitrophenyl)guanidinium picrate
C8H11N4O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 11 o2788-o2789
a=7.1318(10)Å b=10.6239(13)Å c=11.9564(13)Å
α=84.257(10)° β=74.497(11)° γ=77.559(11)°
2-Bromo-1,3-bis(4-chlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica Section E (2009) 65, 11 o2648
a=7.7416(3)Å b=9.7981(4)Å c=9.6717(3)Å
α=90.00° β=109.075(2)° γ=90.00°
3-Methyl-1,2,4-triazolo[3,4-<i>a</i>]phthalazine monohydrate
C10H8N4,H2O
Acta Crystallographica Section E (2009) 65, 11 o2694
a=7.3009(9)Å b=7.9253(9)Å c=9.2755(10)Å
α=109.663(10)° β=104.910(10)° γ=95.830(9)°
(<i>E</i>)-3-(Biphenyl-4-yl)-1-(3-bromophenyl)prop-2-en-1-one
C21H15BrO
Acta Crystallographica Section E (2009) 65, 11 o2856-o2857
a=6.0920(10)Å b=7.2950(10)Å c=36.619(2)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10Cl2O
Acta Crystallographica Section E (2009) 65, 11 o2641-o2642
a=5.8884(9)Å b=7.3328(9)Å c=14.6752(16)Å
α=102.821(10)° β=95.003(10)° γ=92.933(11)°
2-(4-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2009) 65, 12 o3189
a=6.4440(10)Å b=4.0110(10)Å c=35.369(4)Å
α=90.00° β=91.890(10)° γ=90.00°
2-Isopropyl-5-methylcyclohexyl 5-acetoxy-1,3-oxathiolane-2-carboxylate
C16H26O5S
Acta Crystallographica Section E (2009) 65, 12 o3169
a=5.3290(10)Å b=13.8670(10)Å c=23.490(2)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 1 o158
a=5.9197(8)Å b=7.3391(11)Å c=14.8171(17)Å
α=101.929(11)° β=94.371(10)° γ=93.299(11)°
6,11-Dihydrodibenz[<i>b</i>,<i>e</i>]oxepin-11-one
C14H10O2
Acta Crystallographica Section E (2010) 66, 1 o159-o160
a=16.5065(18)Å b=4.0806(7)Å c=15.0392(17)Å
α=90.00° β=93.654(10)° γ=90.00°
Gabapentin-lactum--chloranilic acid (1/1)
C9H15NO,C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 1 o163-o164
a=6.6127(9)Å b=9.5800(11)Å c=13.0724(13)Å
α=102.679(9)° β=91.934(9)° γ=98.481(10)°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-phenylprop-2-en-1-one
C15H11ClO
Acta Crystallographica Section E (2010) 66, 1 o157
a=5.8388(7)Å b=7.5975(11)Å c=13.1300(16)Å
α=83.182(11)° β=89.422(10)° γ=86.662(11)°
11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[<i>b</i>,<i>e</i>]thiepin- 11-ol
C19H23NOS
Acta Crystallographica Section E (2010) 66, 1 o161-o162
a=7.7215(4)Å b=15.3729(10)Å c=27.9274(16)Å
α=90.00° β=95.401(6)° γ=90.00°
Dibenzo[<i>b</i>,<i>e</i>]thiepin-11(6<i>H</i>)-one
C14H10OS
Acta Crystallographica Section E (2010) 66, 2 o350
a=14.6208(11)Å b=4.3503(3)Å c=16.9023(13)Å
α=90.00° β=90.00° γ=90.00°
Chlorimipraminium picrate
C19H24ClN2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 2 o347-o348
a=11.2252(3)Å b=13.1514(3)Å c=17.2787(4)Å
α=90.9414(19)° β=91.1253(19)° γ=100.4446(19)°
Imatinibium dipicrate
C29H33N7O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 2 o411-o412
a=8.560000Å b=10.734000Å c=23.060000Å
α=96.74(3)° β=92.69(2)° γ=101.46(7)°
1-(1,3-Benzodioxol-5-yl)ethanone
C9H8O3
Acta Crystallographica Section E (2010) 66, 2 o383
a=9.4697(3)Å b=10.8445(3)Å c=7.5148(3)Å
α=90.00° β=105.973(3)° γ=90.00°
Valyl benzyl ester chloride
C12H18NO2,Cl
Acta Crystallographica Section E (2010) 66, 2 o324
a=9.7050(10)Å b=5.4060(10)Å c=13.116(2)Å
α=90.00° β=96.580(10)° γ=90.00°
2-Chloro-<i>N</i>-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide
C15H10Cl3NO2
Acta Crystallographica Section E (2010) 66, 2 o499
a=7.5776(9)Å b=10.1565(10)Å c=10.7862(12)Å
α=70.069(8)° β=77.604(9)° γ=70.388(8)°
4-Amino-<i>N</i>-(6-chloro-5-methoxypyrimidin-4-yl)benzenesulfonamide
C11H11ClN4O3S
Acta Crystallographica Section E (2010) 66, 2 o372-o373
a=12.8792(6)Å b=13.3557(6)Å c=8.0867(4)Å
α=90.00° β=102.3960(10)° γ=90.00°
1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 2 o269-o270
a=15.6695(7)Å b=14.1235(8)Å c=5.8455(3)Å
α=90.00° β=90.771(5)° γ=90.00°
<i>N</i>-(5-Amino-2-methylphenyl)-4-(3-pyridyl)pyrimidin-2-amine
C16H15N5
Acta Crystallographica Section E (2010) 66, 2 o349
a=9.2242(3)Å b=12.5399(4)Å c=12.8594(4)Å
α=72.719(3)° β=89.724(3)° γ=77.712(3)°
3-(10,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)- <i>N</i>,<i>N</i>,2-trimethylpropan-1-aminium hydrogen maleate
C20H27N2,C4H3O4
Acta Crystallographica Section E (2010) 66, 2 o366-o367
a=19.4356(4)Å b=11.0542(4)Å c=40.4107(13)Å
α=90.00° β=90.00° γ=90.00°
1-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]ethanone
C17H14F2N2O
Acta Crystallographica Section E (2010) 66, 3 o582-o583
a=7.14470(10)Å b=17.2332(3)Å c=18.4871(4)Å
α=102.8800(10)° β=97.9410(10)° γ=96.3730(10)°
(<i>E</i>)-1-(4-Methylphenyl)ethanone [8-(trifluoromethyl)quinolin-4-yl]hydrazone
C19H16F3N3
Acta Crystallographica Section E (2010) 66, 4 o874
a=8.2811(9)Å b=14.8443(15)Å c=13.5325(15)Å
α=90.00° β=90.601(9)° γ=90.00°
3-(3-Bromo-4-methoxyphenyl)-1,5-diphenylpentane-1,5-dione
C24H21BrO3
Acta Crystallographica Section E (2010) 66, 4 o816
a=12.7305(4)Å b=7.14024(19)Å c=22.8133(8)Å
α=90.00° β=105.602(3)° γ=90.00°
10,10-Dimethylanthrone
C16H14O
Acta Crystallographica Section E (2010) 66, 4 o808-o809
a=11.2438(6)Å b=12.1105(6)Å c=15.1025(8)Å
α=107.9550(10)° β=98.7340(10)° γ=111.7640(10)°
Methyl 4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C20H16F2O3
Acta Crystallographica Section E (2010) 66, 4 o864-o865
a=17.3774(5)Å b=9.0629(3)Å c=22.2238(7)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-methoxy-6-methylpyrimidin-1-ium picrate
C6H10N3O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1189-o1190
a=8.9442(3)Å b=6.2793(3)Å c=27.0354(8)Å
α=90.00° β=94.471(3)° γ=90.00°
2-(4-Methoxyphenyl)-6-trifluoromethyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]quinoline monohydrate
C19H13F3N2O,H2O
Acta Crystallographica Section E (2010) 66, 5 o1111-o1112
a=13.8380(10)Å b=7.0432(5)Å c=17.758(2)Å
α=90.00° β=102.743(8)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-[4-(dimethylamino)phenyl]prop-2-en-1-one
C15H13Cl2NOS
Acta Crystallographica Section E (2010) 66, 5 o1139
a=7.2637(9)Å b=8.1136(9)Å c=13.478(2)Å
α=89.011(9)° β=79.710(10)° γ=73.070(10)°
(2<i>E</i>)-1-(4-Bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H10BrFO
Acta Crystallographica Section E (2010) 66, 5 o1243-o1244
a=4.0060(5)Å b=23.1253(12)Å c=13.4933(9)Å
α=90.00° β=96.344(6)° γ=90.00°
5,7-Dimethyl-2,3-dihydro-1<i>H</i>-1,4-diazepin-4-ium picrate
C7H13N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1187-o1188
a=7.2341(3)Å b=27.6458(6)Å c=8.2831(3)Å
α=90.00° β=110.611(4)° γ=90.00°
5α-androstane-3,17-dione
C19H28O2
Acta Crystallographica Section E (2010) 66, 6 o1517-o1518
a=12.7786(6)Å b=6.7850(4)Å c=19.6242(10)Å
α=90.00° β=106.444(5)° γ=90.00°
(2<i>E</i>)-1-(1,3-Benzodioxol-5-yl)-3-(2-bromophenyl)prop-2-en-1-one
C16H11BrO3
Acta Crystallographica Section E (2010) 66, 6 o1289-o1290
a=5.0434(2)Å b=12.9354(4)Å c=20.8916(7)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(6-methoxy-2-naphthyl)prop-2-en-1-one
C18H12Cl2O2S
Acta Crystallographica Section E (2010) 66, 7 o1717
a=7.3237(5)Å b=9.4919(6)Å c=22.4037(15)Å
α=90.00° β=96.1830(10)° γ=90.00°
(2E)-1-(2-Bromophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 7 o1661
a=12.7300(8)Å b=4.0061(3)Å c=13.0035(6)Å
α=90.00° β=100.671(5)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 7 o1638
a=5.7317(6)Å b=9.3920(7)Å c=23.6517(18)Å
α=90.00° β=91.231(8)° γ=90.00°
(<i>E</i>)-1-(4-Bromophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 8 o1995
a=17.729(4)Å b=4.3505(9)Å c=19.335(4)Å
α=90.00° β=116.93(3)° γ=90.00°
(<i>E</i>)-1-(2-Bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one
C17H15BrO3
Acta Crystallographica Section E (2010) 66, 8 o1952
a=7.7643(9)Å b=9.7006(11)Å c=10.2722(10)Å
α=72.901(10)° β=78.487(9)° γ=86.359(9)°
1-[3,5-Bis(4-chlorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]ethanone
C17H14Cl2N2O
Acta Crystallographica Section E (2010) 66, 8 o1950-o1951
a=6.0716(9)Å b=13.160(2)Å c=19.782(3)Å
α=90.00° β=98.412(2)° γ=90.00°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-ethoxybenzaldehyde trihydrate
C17H16N2O3,3(H2O)
Acta Crystallographica Section E (2010) 66, 8 o2052
a=7.3020(15)Å b=9.3170(19)Å c=25.950(5)Å
α=90.00° β=90.00° γ=90.00°
(2-Methylphenyl)(phenyl)methanol
C14H14O
Acta Crystallographica Section E (2010) 66, 8 o2136
a=23.013(2)Å b=23.013Å c=10.6067(11)Å
α=90° β=90° γ=120°
(<i>E</i>)-3-(4-Methoxyphenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C21H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1996
a=6.0963(11)Å b=10.985(2)Å c=13.133(3)Å
α=74.188(3)° β=88.674(3)° γ=77.393(3)°
3,5-Bis(4-fluorophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C21H16F2N2
Acta Crystallographica Section E (2010) 66, 8 o1948-o1949
a=12.2880(3)Å b=13.1678(3)Å c=11.3245(3)Å
α=90.00° β=112.661(3)° γ=90.00°
8-Bromo-1,3-diphenyl-2,3-dihydro-1<i>H</i>-naphtho[1,2-<i>e</i>][1,3]oxazine
C24H18BrNO
Acta Crystallographica Section E (2010) 66, 8 o2053-o2054
a=7.7617(11)Å b=20.092(3)Å c=11.5094(16)Å
α=90.00° β=91.893(2)° γ=90.00°
2,3-Dibromo-1,3-bis(4-fluorophenyl)propan-1-one
C15H10Br2F2O
Acta Crystallographica Section E (2010) 66, 8 o2018
a=5.7381(13)Å b=9.909(2)Å c=12.575(3)Å
α=75.324(3)° β=87.472(3)° γ=82.300(3)°
4-(4-Chlorophenyl)-4-hydroxypiperidinium maleate maleic acid solvate
C11H15ClNO,C4H3O4,C4H4O4
Acta Crystallographica Section E (2010) 66, 8 o2012-o2013
a=19.282(7)Å b=7.867(3)Å c=25.115(9)Å
α=90.00° β=91.545(5)° γ=90.00°
Opipramol dipicrate
C23H31N3O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 8 o1979-o1980
a=7.3838(8)Å b=12.0400(13)Å c=22.074(2)Å
α=74.8210(10)° β=84.355(2)° γ=73.866(2)°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(4,5-dimethoxy-2-nitrophenyl)prop-2-en-1-one
C17H14BrNO5
Acta Crystallographica Section E (2010) 66, 11 o2936-o2937
a=6.8547(2)Å b=8.3205(2)Å c=27.1509(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
C15H12Cl2O3S
Acta Crystallographica Section E (2010) 66, 10 o2479
a=8.9331(2)Å b=8.9997(2)Å c=18.8210(5)Å
α=90.00° β=100.1810(10)° γ=90.00°
(2<i>E</i>)-3-(1,3-Benzodioxol-5-yl)-1-(3-bromo-2-thienyl)prop-2-en-1-one
C14H9BrO3S
Acta Crystallographica Section E (2010) 66, 10 o2477
a=4.0013(3)Å b=11.0211(9)Å c=14.6931(11)Å
α=90.00° β=95.781(2)° γ=90.00°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(6-methoxy-2-naphthyl)prop-2-en-1-one
C20H15BrO2
Acta Crystallographica Section E (2010) 66, 10 o2552
a=14.0955(14)Å b=6.1295(6)Å c=36.119(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2,4-dichlorophenyl)-6-(6-methoxy-2-naphthyl)-2-oxocyclohex-3-ene- 1-carboxylate
C26H22Cl2O4
Acta Crystallographica Section E (2010) 66, 10 o2478
a=14.2156(4)Å b=5.8647(2)Å c=27.3752(9)Å
α=90.00° β=94.840(2)° γ=90.00°
1-[2-(2-Bromophenyl)ethyl]-4-chloro-2-nitrobenzene
C14H11BrClNO2
Acta Crystallographica Section E (2010) 66, 12 o3358
a=15.7756(4)Å b=7.3795(2)Å c=11.5236(3)Å
α=90.00° β=90.00° γ=90.00°
Levocetirizinium dipicrate
C21H27ClN2O32,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 12 o3167
a=11.24440(10)Å b=15.7720(2)Å c=20.6204(2)Å
α=90.00° β=95.9980(10)° γ=90.00°
Orphenadrinium picrate
C18H24NO,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o190-o191
a=9.9434(10)Å b=11.2216(8)Å c=11.3523(12)Å
α=78.658(7)° β=76.342(9)° γ=87.660(7)°
2-methylimidazolium picrate
C4H7N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o235
a=7.0983(9)Å b=21.644(2)Å c=8.1583(9)Å
α=90.00° β=100.327(12)° γ=90.00°
2-Bromo-1-(3-nitrophenyl)ethanone
C8H6BrNO3
Acta Crystallographica Section E (2011) 67, 1 o29-o30
a=8.8259(7)Å b=8.8651(8)Å c=11.6775(8)Å
α=74.691(7)° β=75.174(7)° γ=78.681(7)°
1-(10<i>H</i>-Phenothiazin-2-yl)ethanone
C14H11NOS
Acta Crystallographica Section E (2011) 67, 2 o430-o431
a=14.3445(18)Å b=5.5425(7)Å c=15.694(2)Å
α=90.00° β=114.494(2)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one
C15H12BrNO2
Acta Crystallographica Section E (2011) 67, 2 o352-o353
a=26.3402(13)Å b=3.8906(2)Å c=27.5826(17)Å
α=90.00° β=113.892(5)° γ=90.00°
3,5-Bis(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2O2
Acta Crystallographica Section E (2011) 67, 2 o328-o329
a=9.4788(5)Å b=10.1893(6)Å c=19.9139(10)Å
α=90° β=92.296(4)° γ=90°
(2<i>E</i>)-3-[4-(Dimethylamino)phenyl]-1-(4-fluorophenyl)prop-2-en-1-one
C17H16FNO
Acta Crystallographica Section E (2011) 67, 2 o313-o314
a=12.8334(3)Å b=12.3560(2)Å c=9.3922(2)Å
α=90.00° β=105.965(2)° γ=90.00°
(<i>E</i>)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one
C17H16O4
Acta Crystallographica Section E (2011) 67, 4 o845
a=14.2315(2)Å b=8.02920(10)Å c=13.6027(2)Å
α=90.00° β=110.0531(14)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
C17H15BrO2
Acta Crystallographica Section E (2011) 67, 4 o1024
a=11.680(2)Å b=11.654(2)Å c=10.834(2)Å
α=90.00° β=93.07(2)° γ=90.00°
(2<i>E</i>)-3-(4-Chlorophenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
C15H11ClO2
Acta Crystallographica Section E (2011) 67, 4 o756
a=7.3570(2)Å b=15.6450(5)Å c=10.4954(3)Å
α=90.00° β=90.518(3)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one
C16H12BrFO2
Acta Crystallographica Section E (2011) 67, 5 o1090
a=11.056(2)Å b=4.1110(15)Å c=30.825(5)Å
α=90.00° β=96.76(2)° γ=90.00°
(2<i>E</i>)-3-[4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)phenyl]- 1-(4-methoxyphenyl)prop-2-en-1-one
C24H20N2O3
Acta Crystallographica Section E (2011) 67, 5 o1088-o1089
a=7.2244(5)Å b=9.3201(8)Å c=14.9422(9)Å
α=98.449(2)° β=99.183(4)° γ=99.478(4)°
3-Fluoroanilinium 4-methylbenzenesulfonate
C6H7FN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2924
a=14.5385(7)Å b=6.4939(3)Å c=14.5522(7)Å
α=90.00° β=91.429(4)° γ=90.00°
Opipramol dihydrochloride
C23H31N3O2,2(Cl)
Acta Crystallographica Section E (2011) 67, 11 o2994-o2995
a=33.6581(6)Å b=9.4265(2)Å c=6.89780(10)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(3,4-Dichlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
C15H10Cl2O2
Acta Crystallographica Section E (2012) 68, 2 o366
a=7.2551(6)Å b=7.8351(7)Å c=12.8049(11)Å
α=92.367(7)° β=102.946(8)° γ=109.011(8)°
1,3-Bis(biphenyl-4-yl)-2,2-dibromo-3-oxopropyl acetate
C29H22Br2O3
Acta Crystallographica Section E (2012) 68, 2 o362-o363
a=12.0497(14)Å b=20.842(2)Å c=9.9482(10)Å
α=90.00° β=98.743(10)° γ=90.00°
(2<i>E</i>)-1-(2,6-Dichloro-3-fluorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H8Cl2F2O
Acta Crystallographica Section E (2012) 68, 2 o512
a=12.2311(3)Å b=10.3115(2)Å c=11.2468(3)Å
α=90.00° β=108.9350(10)° γ=90.00°
1-(2-Hydroxyethyl)-4-[3-(2-trifluoromethyl-9<i>H</i>-thioxanthen-9- ylidene)propyl]piperazine-1,4-diium dichloride
C23H27F3N2OS2,2(Cl)
Acta Crystallographica Section E (2011) 67, 8 o2079-o2080
a=34.1750(17)Å b=7.1613(3)Å c=22.6351(11)Å
α=90° β=115.307(6)° γ=90°
9-[3-(Dimethylamino)propyl]-2-trifluoromethyl-9<i>H</i>-thioxanthen-9-ol
C19H20F3NOS
Acta Crystallographica Section E (2011) 67, 8 o1883
a=7.6183(3)Å b=13.9605(4)Å c=17.4172(7)Å
α=90.00° β=101.053(4)° γ=90.00°
1-(2-Hydroxyethyl)-4-{3-[(<i>E</i>)-2-(trifluoromethyl)-9<i>H</i>-thioxanthen- 9-ylidene]propyl}piperazine-1,4-diium bis(3-carboxyprop-2-enoate)
C23H27F3N2OS2,2(C4H3O4)
Acta Crystallographica Section E (2011) 67, 8 o2017-o2018
a=6.4175(2)Å b=9.6185(4)Å c=25.5771(10)Å
α=96.377(4)° β=96.295(3)° γ=92.774(3)°
2-(4-Bromophenyl)-<i>N</i>-(pyrazin-2-yl)acetamide
C12H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o891
a=10.6804(4)Å b=7.5196(3)Å c=29.1355(10)Å
α=90° β=90° γ=90°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)-2-(4-nitrophenyl)acetamide
C19H18N4O4
Acta Crystallographica Section E (2014) 70, 6 o636-o637
a=6.7023(6)Å b=8.6335(8)Å c=15.8720(13)Å
α=76.305(7)° β=84.399(7)° γ=77.252(7)°
Flunarizinium isonicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section E (2014) 70, 6 o681-o682
a=11.0023(3)Å b=10.6435(3)Å c=11.3393(3)Å
α=90° β=92.481(3)° γ=90°
Pyrimethaminium 2-{[4-(trifluoromethyl)phenyl]sulfanyl}benzoate dimethyl sulfoxide monosolvate
C12H14ClN4,C14H8F3O2S,C2H6OS
Acta Crystallographica Section E (2014) 70, 6 o683-o684
a=12.7422(3)Å b=22.2773(3)Å c=11.1761(3)Å
α=90° β=114.014(3)° γ=90°
4-pyrimidin-2-yl-piperazin-1-ium fumarate
C8H13N4,C4H3O4
Acta Crystallographica Section E (2014) 70, 6 o702-o703
a=12.3425(5)Å b=7.0365(3)Å c=14.7178(6)Å
α=90° β=94.213(3)° γ=90°
1(2-Furoyl)piperazinium 3,5-dinitrobenzoate
C9H13N2O2,C7H3N2O6
Acta Crystallographica Section E (2014) 70, 6 o700-o701
a=9.6060(2)Å b=10.4572(2)Å c=33.8766(7)Å
α=90° β=90° γ=90°
Cyclobenzaprinium salicylate
C20H22N,C7H5O3
Acta Crystallographica Section E (2011) 67, 7 o1584
a=7.4700(8)Å b=10.8408(12)Å c=14.9724(16)Å
α=76.073(2)° β=77.3570(10)° γ=72.574(2)°
Melitraceninium chloride
C21H26N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1725
a=15.0129(18)Å b=8.8092(11)Å c=14.0135(17)Å
α=90.00° β=91.506(2)° γ=90.00°
4-(4-Chlorophenyl)-4-hydroxypiperidinium 2-(2-phenylethyl)benzoate
C11H15ClNO,C15H13O2
Acta Crystallographica Section E (2011) 67, 7 o1726
a=13.1016(2)Å b=10.2963(2)Å c=16.8015(3)Å
α=90.00° β=98.2340(10)° γ=90.00°
2,2-Diphenyl-4-(piperidin-1-yl)butanamide
C21H26N2O
Acta Crystallographica Section E (2011) 67, 7 o1827
a=18.1070(12)Å b=10.3025(9)Å c=9.6150(6)Å
α=90.00° β=90.00° γ=90.00°
7-Methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one
C11H12O2
Acta Crystallographica Section E (2011) 67, 7 o1646
a=7.4303(4)Å b=7.4614(4)Å c=16.4393(8)Å
α=90.00° β=90.976(4)° γ=90.00°
3-Chloro-<i>N</i>-(4-methoxyphenyl)propanamide
C10H12ClNO2
Acta Crystallographica Section E (2011) 67, 11 o2868
a=9.6326(3)Å b=8.6650(2)Å c=25.7944(8)Å
α=90.00° β=90.00° γ=90.00°
4-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 12 o3288-o3289
a=5.7253(5)Å b=7.5160(6)Å c=15.7642(13)Å
α=95.166(6)° β=96.148(7)° γ=92.353(7)°
Paliperidone
C23H27FN4O3
Acta Crystallographica Section E (2011) 67, 11 o2945-o2946
a=6.85370(10)Å b=21.5613(5)Å c=15.3472(3)Å
α=90.00° β=113.8570(10)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichlorothiophen-3-yl)ethanone [8-(trifluoromethyl)quinolin-4-yl]hydrazone
C16H10Cl2F3N3S
Acta Crystallographica Section E (2012) 68, 3 o790
a=7.687(2)Å b=14.392(5)Å c=14.360(5)Å
α=90.00° β=95.053(9)° γ=90.00°
Methyl 2,2-diphenyl-2-(prop-2-yn-1-yloxy)acetate
C18H16O3
Acta Crystallographica Section E (2012) 68, 3 o874
a=12.6771(17)Å b=9.2410(13)Å c=12.7055(18)Å
α=90.00° β=93.090(3)° γ=90.00°
Ethyl <i>N</i>-(2-benzoyl-4-chlorophenyl)ethanecarboximidate
C17H16ClNO2
Acta Crystallographica Section E (2012) 68, 3 o916
a=7.9674(11)Å b=8.6993(17)Å c=11.596(2)Å
α=104.499(17)° β=94.871(14)° γ=95.001(14)°
Ethyl 2-amino-4,6-bis(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19F2NO2
Acta Crystallographica Section E (2012) 68, 3 o585
a=18.0199(5)Å b=9.6391(2)Å c=21.0754(7)Å
α=90.00° β=90.00° γ=90.00°